SFC

CARDIOLOGIE PEDIATRIQUE

  • Incremental Detection of Severe Congenital Heart Disease by Fetal Echocardiography Following a Normal Second Trimester Ultrasound Scan in Québec, Canada [AHA JOURNALS]
  • Prevalence and Prognostic Implications of Left Ventricular Systolic Dysfunction in Adults With Congenital Heart Disease [JACC]
  • Late Balloon Valvuloplasty for Transcatheter Heart Valve Dysfunction [JACC]
  • Placental Findings in Pregnancies Complicated by Maternal Cardiovascular Disease [JACC]
  • Clinical Features and Outcomes in Adults With Childhood Repair of Partial Atrioventricular Septal Defect [JACC]
  • Current-Era Outcomes of Balloon Aortic Valvotomy in Neonates and Infants [JACC]
  • Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure [AHA JOURNALS]
  • Born to Age: When Adult Congenital Heart Disease Converges With Geroscience [JACC]

CARDIO-ONCOLOGIE

  • The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review [SCIENCE DIRECT]
  • Incident Cardiovascular Disease Among Adults With Cancer: A Population-Based Cohort Study [SCIENCE DIRECT]

CORONAIRES ET INTERVENTIONNEL

  • Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study [ACADEMIC]
  • Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial [ACADEMIC]
  • Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease [ACADEMIC]
  • Impact of Ticagrelor Versus Clopidogrel on Coronary Microvascular Function After Non–ST-Segment–Elevation Acute Coronary Syndrome [AHA JOURNALS]
  • Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry [JACC]
  • Treatment of Coronary De Novo Lesions by a Sirolimus- or Paclitaxel-Coated Balloon [JACC]
  • Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy [JACC]
  • Quality of Life After Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery [AHA JOURNALS]
  • Efficacy of Diltiazem to improve coronary vasomotor dysfunction in angina and nonobstructive coronary arteries (ANOCA): Results of the EDIT-CMD randomized clinical trial [JACC]
  • A Simulation Study of the Effects of Number and Location of MitraClips on Mitral Regurgitation [JACC]

HTA

  • Association of Cumulative Blood Pressure With Cognitive Decline, Dementia, and Mortality [JACC]
  • Treatment for Mild Chronic Hypertension during Pregnancy [NEJM]

IMAGERIE CARDIOVASCULAIRE

  • CAC for Risk Stratification Among Individuals With Hypertriglyceridemia Free of Clinical Atherosclerotic Cardiovascular Disease [JACC]
  • Prognostic Significance of Cardiac 123I-MIBG SPECT Imaging in Heart Failure Patients With Preserved Ejection Fraction [JACC]

INSUFFISANCE CARDIAQUE – CARDIOMYOPATHIES

  • 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [AHA JOURNALS]
  • A Deep Learning Model for Inferring Elevated Pulmonary Capillary Wedge Pressures From the 12-Lead Electrocardiogram [JACC]
  • Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS) [AHA JOURNALS]
  • Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial [JACC]

RISQUE CARDIOVASCULAIRE

  • Childhood Risk Factors and Prediction of Adult Cardiovascular End Points [NEJM]
  • Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events [NEJM]
  • Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70 [AHA JOURNALS]

RYTHMOLOGIE

  • Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers [JAMA NETWORK]
  • Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial [AHA JOURNALS]
  • Prediction of Sudden Cardiac Death Manifesting With Documented Ventricular Fibrillation or Pulseless Ventricular Tachycardia [JACC]
  • Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemis Stroke [JACC]
  • Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation [ACADEMIC]
  • Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke [JACC]
  • Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry [AHA JOURNALS]
  • Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry [JACC]
  • Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial [AHA JOURNALS]

USIC

  • Tranexamic Acid in Patients Undergoing Noncardiac Surgery [NEJM]

VALVULOPATHIES

  • Comparison between Bicuspid and Tricuspid Aortic Regurgitation: Presentation, Survival and Aorta Complications [JACC]

COVID

  • Effect of Early Treatment with Ivermectin among Patients with Covid-19 [NEJM]
  • Early Outpatient Treatment for Covid-19 with Convalescent Plasma [NEJM]
  • BNT162b2 Protection against the Omicron Variant in Children and Adolescents [NEJM]
  • Protection by a Fourth Dose of BNT162b2 against Omicron in Israel [NEJM]
  • Trends in Clinical Characteristics, Management Strategies and Outcomes of STEMI Patients with COVID-19 [JACC]
  • Prospective Evaluation of Autonomic Dysfunction in Post-Acute Sequela of COVID-19 [JACC]

LA FRANCE A L’HONNEUR

  • Coronary artery calcifications and 6-month mortality in patients with COVID-19 without known atheromatous disease [SCIENCE DIRECT]

Nos suggestions d’actualités

Les actualités Cardio Online

La muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

22/11/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 22/11/24

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !